Table 2. Imaging indications and findings in patients with neurologic symptoms associated with babesiosis admitted to Yale-New Haven Hospital, New Haven, Connecticut, USA, January 2011–October 2021*.
| Imaging | No. (%) patients |
|---|---|
| Neuroimaging modality | |
| Computed tomography | 28 (17.2) |
| Magnetic resonance imaging | 7 (4.3) |
| Electroencephalogram |
2 (1.2) |
| Indication | |
| Altered mental status/confusion | 15 (9.2) |
| Headache | 8 (4.9) |
| Fever | 5 (3.1) |
| Evaluate CNS abnormalities | 3 (1.8) |
| Weakness | 3 (1.8) |
| Dizziness | 1 (0.6) |
| Dysphagia, slurred speech | 1 (0.6) |
| Fall | 1 (0.6) |
| Head injury | 1 (0.6) |
| Visual changes | 1 (0.6) |
| Syncope | 1 (0.6) |
| Numbness | 1 (0.6) |
| Fatigue | 1 (0.6) |
| Seizure |
1 (0.6) |
| Findings | |
| Nonspecific white matter changes | 23 (14.1) |
| Volume loss | 14 (8.6) |
| Acute changes | 2 (1.2) |
| Evidence of previous stroke | 3 (1.8) |
*Total sample consisted of 163 patients. Neuroimaging modalities and indications sum to >33 because some patients received multiple imaging modalities or had multiple indications. CNS, central nervous system.